Global Biologics Market

 decision foresight.png

Global Biologics Market Size, Share, Growth, Industry Trends and Forecast 2020-2030


Biologics are pharmaceutical products derived from living cells or micro-organisms. These are complex and large molecules comprising of proteins, peptides, nucleic acids, sugars, cellular structures or a combination of all the above. The biologics drug discovery process involves target identification, hit-to-lead stage, lead identification & optimization. Technologies applied for the development of biologics include genomics, proteomics, microarrays, cell cultures, phage display technologies and monoclonal antibody technologies. Biologics include genes that control production of vital proteins; proteins that control the action of other proteins and cellular processes; and modify human hormones or cells that produce products that suppress or activate the components of the immune system. They are used for the treatment of various diseases such as rheumatoid arthritis, ulcerative colitis, and other autoimmune diseases. The common side effects of biologics drugs observed are weakness, chills, allergic reactions, nausea, diarrhoea, itching, vomiting, injection side reaction, constipation, cough, headache, fever, shortness of breath, fever, dizziness, and others. The major biologics drugs presently available in the market are Humira, Remicade, Enbrel, Avastin and Herceptin. The global biologics market is projected to reach USD 559.6 billion by 2030 from USD 274.1 billion in 2020, at an approximate CAGR of 7.40%.

Download Sample Copy of the Report to understand the structure of the complete report (Including Full TOC, Table & Figures) @ https://www.decisionforesight.com/request-sample/DFS020111

Market Dynamics and Factors:

Rising prevalence of chronic diseases, incessant research and development activities, and continuous investment in biologics are the major factors attributing to the market growth of the biologics market across the globe. For instance, according to the World Health Organization (WHO), by 2020 chronic diseases would constitute around 75% of the total deaths worldwide.  Cancer, autoimmune diseases, and diabetes attribute to almost 60% of the overall biologics market. In 2016, approximately 50% of the new molecular units approved by the Food and Drug Administration were biologics. Continuous advancements in cellular & gene therapy further catalyses the market because of its high efficacy and therapeutic outcome. Furthermore, other major factors such as rising expenditure on healthcare, increased availability of advanced diagnostics, and growing applications of monoclonal antibodies for the treatment of different diseases are also positively impacting the overall growth of the global biologics market. However, certain factors like the emergence of biosimilars, high cost of biologics, lack of oral absorption and operational challenges are restraining the market growth of the global biologics market

Market Segmentation :

  • Global Biologics Market – By Source

    • Microbial

    • Mammalian

    • Others

  • Global Biologics Market – By Product Type

    • Monoclonal Antibody

    • Interleukins

    • Vaccines

    • Growth Factors

    • Gene Therapy

    • Others

  • Global Biologics Market – By Disease Indication

    • Immunological Disorders

    • Cardiovascular Disorders

    • Hematological Disorders

    • Cancer

    • Arthritis

    • Diabetes

    • Others

  • Global Biologics Market – By Geography

    • North America

      • U.S.

      • Canada

      • Mexico

    • Europe

      • U.K.

      • France

      • Germany

      • Italy

      • Rest of Europe

    • Asia-Pacific

      • Japan

      • China

      • India

      • Australia

      • Rest of Asia Pacific

    • ROW

      • Latin America

      • Middle East

      • Africa

New Business Strategies, Challenges & Policies are mentioned in Table of Content, Request TOC at @ https://www.decisionforesight.com/toc-request/DFS020111

Geographic Analysis:

North America is expected to dominate the global biologics market in terms of market share during the forecast period. The presence of key market players, continuous R&D in the biologics field, growing prevalence of chronic disorders, and longer patent protection compared to other regions are the major factors attributing to the market dominance of the region. For instance, U.S. pharmaceutical companies’ account for almost 80% of the world’s R&D in health care biotechnology. The Asia Pacific region is anticipated to witness the fastest growth in the biologics market during the forecast period. Expansion of international players in developing nations contribute to the biologics market growth in the APAC region. For instance, Novartis AG wishes to launch its FDA approved treatment Kymriah in Japan. Additionally, there has been a spurt of heavy investments by Asian contract manufacturers in order to grab share in the global biologics market. Companies such as Samsung Biologics and Wuxi Biologics are anticipated to drive the market growth in the Asian region.     

Competitive Scenario :

The key players operating in the global biologics market are –

AbbVie Inc., Amgen Inc., Pfizer Inc., Novartis AG, GlaxoSmithKline Plc, Bayer AG, Sanofi, Hoffman La-Roche, Samsung Biologics, Eli Lilly & Company, Merck & Co., Johnson & Johnson Services Inc.   

Connect to Analyst @ https://www.decisionforesight.com/speak-analyst/DFS020111

How will this Market Intelligence Report Benefit You?

  1. The report offers statistical data in terms of value (US$) as well as Volume (units) till 2030.

  2. Exclusive insight into the key trends affecting the Global Biologics industry, although key threats, opportunities and disruptive technologies that could shape the Global Biologics Market supply and demand.

  3. The report tracks the leading market players that will shape and impact the Global Biologics Market most.

  4. The data analysis present in the Global Biologics Market report is based on the combination of both primary and secondary resources.

  5. The report helps you to understand the real effects of key market drivers or retainers on Global Biologics Market business.

The 2021 Annual Global Biologics Market offers:

  • 100+ charts exploring and analysing the Global Biologics Market from critical angles including retail forecasts, consumer demand, production and more

  • 15+ profiles of top producing states, with highlights of market conditions and retail trends

  • Regulatory outlook, best practices, and future considerations for manufacturers and industry players seeking to meet consumer demand

  • Benchmark wholesale prices, market position, plus prices for raw materials involved in Global Biologics Market type

Buy This Premium Research Report@ https://www.decisionforesight.com/checkout/DFS020111

About Us:

Decision Foresight is a market research organization known for its reliable and genuine content, market estimation and the best analysis which is designed to deliver state-of-the-art quality syndicate reports to our customers. Apart from syndicate reports, you will find the best market insights, strategies that will help in taking better business decisions on subjects that may require you to develop and grow your business-like health, science, technology and many more. At Decision Foresight, we truly believe in disseminating the right piece of knowledge to a large section of the audience and cover the in-depth insights of market leaders across various verticals and horizontals.

Contact:

Email: sales@decisionforesight.com

For Latest Update Follow Us:

https://www.facebook.com/Decision-Foresight-110793387201935

https://twitter.com/DecisionFs

https://www.linkedin.com/company/decision-foresight/

Comments

Post a Comment

Popular posts from this blog

Digital Pathology

Image
  Global Digital Pathology Market Size, Share, Growth, Industry Trends and Forecast 2020-2030 Global Digital Pathology Market accounted USD 721.7 million in 2020 and is anticipated to reach USD 2281.7469 million by 2030, at a CAGR of 12.2% during the forecast period. It is an innovation predominantly committed to minimize laboratory expenses, increase operational efficiency, improving treatment decisions and patient care, and improved overall productivity. This technique incorporates the management, acquisition, sharing and interpretation of pathology information — which include slides and data — in a digital environment. Digital slides are produced when glass slides are apprehended with a scanning device, to deliver a high-resolution digital image that can be observed on a computer screen or mobile device. Virtual microscopy is a part of the market which enables to practice converting glass slides into digital slides that can be viewed, managed, shared and analyzed on a computer m...
Read more

Global Antisense And RNAi Therapeutics Market

Image
  Global Antisense And RNAi Therapeutics Market Size, Share, Growth, Industry Trends and Forecast 2020-2030 Antisense and RNAi therapeutics are therapeutic treatments having the potential to treat diseases such as chronic liver and cardiovascular diseases, and other rare diseases. Antisense RNAi was the largest technology segment in 2018 due to technological advancement in the healthcare sector. Antisense technology is a method that can stop protein production. Antisense technology can be used to design new therapeutics for certain new diseases. The principle behind is antisense nucleic acid sequence base pairs with complementary sense RNA strand and avoids from being translated into a protein. Based on the triggering of the RNA molecules this technology is segmented into siRNA and miRNA. Antisense and RNAi therapeutics services are applicable in the treatment of a wide range of diseases that target nucleic acid and affect the cell growth cycle. miRNA has the ability to restore gen...
Read more

Regenerative Therapies

Image
  Global Regenerative Therapies Market Size, Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts to 2030 The Global regenerative therapies market held USD 8.5 billion in 2020 and is to grow with a CAGR of 15.7% from 2020-2030. Regenerative medicine is medicine principle that focuses on the replacement of tissues, human cells and organs in order to restore normal functionality. Regenerative medicine aims to renew or replace cells in the damaged and unfitting tissue or organ of human beings. The body's own cells can be encouraged to cure, or a patient with laboratories-grown cells and tissues can be therapied. It can treat incurable chronic disorders and conditions such as Alzheimer's disease, Parkinson's disease, diabetes, cardiac illness, kidney failure, osteoporosis and injuries to the spinal cord, etc. Download Sample Copy of the Report to understand the structure of the complete report (Including Full TOC, Tabl...
Read more